ADC Linker

Amino-PEG8-Boc is a cleavable eight-unit polyethylene glycol (PEG) linker utilized in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates improved stability and solubility in ADC formulations. Additionally, Amino-PEG8-Boc serves as a PEG-based linker for the development of protein-targeting chimeras (PROTACs), allowing for innovative therapeutic applications in targeted protein degradation studies.

m-PEG4-Amine is a PEG-based linker primarily utilized in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This compound features a cleavable link, enabling the targeted delivery of therapeutic agents while providing controlled release upon cellular internalization. Its application is pivotal in advancing research in targeted protein degradation and therapeutic modalities, enhancing drug efficacy and specificity in various biological systems.

Azide-C2-SS-C2-biotin is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). Featuring an azide functionality, it facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and supports strain-promoted alkyne-azide cycloaddition (SPAAC) when interacting with DBCO or BCN groups. This reagent is essential for the development of targeted therapeutic strategies in bioconjugation research and ADC formulation.

NH2-PEG8-acid is a non-cleavable linker composed of an 8-unit polyethylene glycol (PEG) chain, which is utilized in the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates the conjugation of therapeutic agents to antibodies, enhancing the delivery and efficacy of targeted therapies. Additionally, NH2-PEG8-acid serves as a PEG-based linker in the development of PROTACs (proteolysis-targeting chimeras), allowing for precise modulation of protein degradation pathways in research applications.

DBCO-Sulfo-Link-biotin is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It features a DBCO moiety that enables efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing compounds. This reagent is valuable in the development of targeted therapies, facilitating precise delivery of cytotoxic agents to tumor cells while minimizing off-target effects. Its application enhances the effectiveness of therapeutic strategies in oncology and related fields.

Propargyl-PEG4-NHS ester is a stable, non-cleavable linker designed for antibody-drug conjugates (ADCs) through its ability to facilitate click chemistry reactions. This reagent features an alkyne group, allowing it to engage in copper-catalyzed azide-alkyne cycloaddition (CuAAC) with azide-containing molecules. Its streamlined conjugation capabilities make it valuable for the development of targeted therapies and bioconjugation applications in chemical biology and pharmaceuticals.

endo-BCN-PEG4-acid is a versatile cleavable linker designed for antibody-drug conjugates (ADCs), facilitating targeted drug delivery. Featuring a bicyclo[6.1.0]nonyne (BCN) moiety, this compound enables efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. It is particularly useful in bioconjugation and drug development applications, allowing for the precise attachment of therapeutic agents to antibodies.

4-Azidobenzyl alcohol is an azide compound primarily utilized in click chemistry applications. It features an azide group that can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, enabling the formation of stable triazole linkages. Additionally, this reagent can engage in strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with DBCO or BCN groups, making it valuable for bioconjugation and surface modification studies in chemical biology.

Propargyl-C1-NHS ester is a non-cleavable linker specifically designed for antibody-drug conjugation (ADC). This reagent features an alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Its applications are significant in bioconjugation techniques, enhancing the precision of targeted therapeutics in chemical biology research.

Fmoc-azetidine-3-carboxylic acid is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. It serves as an effective alkyl chain-based PROTAC linker for the development of proteolysis-targeting chimeras (PROTACs). This compound facilitates targeted drug delivery and enhances the therapeutic efficacy of conjugates, making it a valuable tool for chemical biology and drug discovery research. Its distinct characteristics allow for precise modifications, thereby supporting innovative applications in ADC and PROTAC design.

H-Glu-OtBu is a non-cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates stable attachment between antibodies and drug moieties, enhancing the efficacy and targeting of ADCs in therapeutic applications. Additionally, H-Glu-OtBu serves as an alkyl chain-based linker in the development of PROTACs, enabling the targeted degradation of proteins. Its versatile functionality makes it an essential reagent in chemical research and drug development.

MC-VC-PAB-NH2 TFA is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). It facilitates the conjugation of cytotoxic agents to antibodies, allowing for targeted delivery of therapeutics. This compound plays a critical role in enhancing the efficacy of ADCs by ensuring selective release of the drug in the tumor microenvironment. Its utilization is pivotal in the development of advanced cancer therapies.

m-PEG7-CH2CH2COOH is a PEG-based PROTAC linker designed to facilitate the synthesis of targeted protein degraders. It serves as a non-cleavable linker in the development of antibody-drug conjugates (ADCs), enhancing the delivery of therapeutic agents. This compound is crucial for researchers working on PROTAC technology and ADC chemistry, enabling better modulation of protein levels in various biological systems. Its unique structure supports effective conjugation and stability for experimental applications in drug development.

Fmoc-Gly-NH-CH2-O-CH2COOH is an ADC linker designed for use in antibody-drug conjugate synthesis. This compound features a glycine residue that facilitates the covalent attachment of cytotoxic drugs to monoclonal antibodies, enabling targeted delivery to tumor cells. Its structural properties enhance the stability and efficacy of the resulting ADCs in therapeutic applications.

Propargyl-PEG2-acid is a non-cleavable linker targeting the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This PEG-based compound facilitates the conjugation process through click chemistry, featuring an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. It serves as a vital tool for researchers in the development of innovative therapeutic strategies involving ADCs and targeted protein degradation applications.

N-Boc-PEG5-bromide is a PEG-based linker designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras) and antibody-drug conjugates (ADCs). This cleavable linker facilitates the efficient conjugation of therapeutic agents to antibodies, enabling targeted delivery and enhanced therapeutic efficacy. Its application extends to various research areas in bioconjugation and drug development, making it a valuable tool for advancing therapeutic strategies in cancer and other diseases.

m-PEG4-Br is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs) for enhanced therapeutic efficacy. By distally connecting to the monomethyl auristatin E (MMAE) payload, m-PEG4-Br modulates hydrophilicity, antigen binding, and in vitro potency of the ADC. Additionally, this versatile compound serves as a PROTAC linker, facilitating the development of PROTACs for targeted protein degradation studies.

Mal-VC-PAB-PNP is a cleavable ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective delivery of cytotoxic agents to target cells, enhancing therapeutic efficacy while minimizing off-target effects. Its versatile application in ADC development makes it a valuable reagent in cancer research and drug delivery systems.

Ald-Ph-NHS ester is a non-cleavable linker targeting antibody-drug conjugation (ADC) applications. This compound facilitates the stable conjugation of antibodies to cytotoxic agents, enhancing the therapeutic efficacy of ADCs. Its robust linkage ensures effective delivery of pharmacological agents to targeted cells, thereby supporting research in targeted cancer therapies and bioconjugation methodologies.

Boc-Val-Cit-PAB is a cleavable linker specifically designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective release of payloads in targeted cancer therapies, enhancing the efficacy of the conjugate while minimizing off-target effects. Its utility in ADC development allows for the precise delivery of cytotoxic agents to cancer cells, promoting advancements in personalized treatment strategies.

Hydroxy-PEG4-(CH2)2-Boc is an uncleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs), facilitating stable conjugation between antibodies and therapeutic agents. Its structure supports efficient delivery of cytotoxic drugs specifically to target cells, enhancing therapeutic efficacy while minimizing off-target effects. Additionally, Hydroxy-PEG4-(CH2)2-Boc serves as a PROTAC linker, making it suitable for the development of proteolysis-targeting chimeras that promote the targeted degradation of specific proteins in various research applications.

1-Boc-azetidine-3-carboxylic acid is a non-cleavable linker targeting antibody-drug conjugates (ADCs) and is utilized in the synthesis of ADCs. This compound also serves as an alkyl chain-based linker for the development of proteolysis-targeting chimeras (PROTACs). Its robust structural features make it suitable for enhancing the efficacy and stability of conjugated drugs in various biopharmaceutical research applications.

Fmoc-Asp-NH2 is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the conjugation of therapeutic agents to antibodies, enhancing the selectivity and potency of ADCs. Fmoc-Asp-NH2 is critical for optimizing drug delivery and improving therapeutic efficacy in targeted cancer therapies. Its use in research supports the development of innovative treatments by enabling the precise delivery of cytotoxic agents to malignancies.

S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate is a glutathione-cleavable linker primarily used in antibody-drug conjugates (ADCs). This compound facilitates the covalent attachment of monoclonal antibodies to cytotoxic agents, enabling selective delivery and targeted therapy. Its unique design enhances the stability of ADCs in circulation while allowing for effective release within targeted tumor environments, making it a valuable tool in cancer research and therapeutic applications.

Bis-PEG25-NHS ester is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and antibody-drug conjugates (ADCs). Featuring a cleavable NHS ester moiety, this compound enables precise conjugation and release of biomolecules, facilitating targeted therapeutic strategies. Its versatility makes it suitable for a variety of applications in chemical biology and drug development, particularly in enhancing the selectivity and efficacy of therapeutic agents.

NH2-PEG6-CH2CH2COOH is a cleavable six-unit polyethylene glycol (PEG) linker specifically designed for antibody-drug conjugate (ADC) applications. This versatile compound facilitates the attachment of drugs to antibodies, enhancing therapeutic efficacy. Additionally, NH2-PEG6-CH2CH2COOH serves as a PEG-based linker for the development of PROTACs, supporting targeted protein degradation research. Its unique structure allows for improved solubility and bioavailability in various biological assays.

BCN-PEG4-NHS ester is a PEG-based linker specifically designed for the synthesis of PROTACs (Proteolysis Targeting Chimeras). Its primary mechanism involves the BCN group, which facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. This reagent is essential for enabling targeted protein degradation and enhancing the therapeutic potential of PROTACs in chemical biology research. Additionally, it serves as an effective tool for bioconjugation applications, expanding the versatility of synthetic approaches in drug discovery.

Alloc-Val-Ala-pAB is a peptide-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). The Val-Ala segment is selectively cleaved by the enzyme Cathepsin B, facilitating the targeted release of cytotoxic agents. The Alloc group exhibits stability under treatment with piperidine and TFA, yet can be efficiently removed under mild conditions through palladium-catalyzed allyl transfer, making it a versatile component for precise drug delivery applications.

γ-Glu-Val-Gly is a cleavable linker widely utilized in antibody-drug conjugates (ADCs). This compound features a peptide bond susceptible to enzymatic cleavage, enabling the selective release of cytotoxic agents within target cells. Its application in ADC development supports targeted cancer therapy by enhancing the delivery and efficacy of therapeutic agents while minimizing systemic toxicity.

Fmoc-D-Lys(N3)-OH is a chemical reagent featuring an azide moiety, which serves as a key element in click chemistry applications. This compound can participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules and can also undergo strain-promoted azide-alkyne cycloaddition (SPAAC) with dibenzocyclooctyne (DBCO) or bicyclononyne (BCN) functionalities. Fmoc-D-Lys(N3)-OH is valuable for various biochemical research applications, particularly in the development of bioconjugates and chemical probes.

Azido-PEG8-acid is a non-cleavable linker composed of eight polyethylene glycol (PEG) units, specifically designed for use in antibody-drug conjugates (ADCs) and PROTACs. It serves as a versatile click chemistry reagent due to its azide functionality, facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it supports strain-promoted alkyne-azide cycloaddition (SPAAC) reactions when interacting with DBCO or BCN groups. This compound is essential for researchers focusing on the development of targeted therapeutic agents and protein degradation strategies.

DBCO-NHCO-S-S-NHS ester is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound contains a DBCO group, facilitating strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its application is crucial in the construction of targeted therapies, enabling the selective delivery of cytotoxic agents to specific cells.

Boc-Val-Ala-PAB-PNP is a cleavable linker designed for the development of antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents in targeted cancer therapies, making it invaluable for the construction of ADCs. Its specific design allows for stable attachment to antibodies while enabling controlled drug release in the tumor microenvironment, thus enhancing therapeutic efficacy.

1-Boc-azetidine-3-yl-methanol serves as a non-cleavable linker in the synthesis of antibody-drug conjugates (ADCs). This compound is also utilized as an alkyl chain-based linker in the development of proteolysis-targeting chimeras (PROTACs). Its unique chemical structure facilitates the effective conjugation of therapeutic agents, enhancing delivery and efficacy in targeted cancer therapies.

Boc-Hyp-OMe is a non-cleavable linker that serves as an essential component in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. Its alkyl chain structure facilitates the conjugation of therapeutic agents, enabling targeted delivery and improved therapeutic efficacy. Boc-Hyp-OMe is valuable for researchers focusing on drug development and molecular biology, particularly in studies involving targeted protein degradation and the design of innovative therapeutic modalities.

Fmoc-NH-ethyl-SS-propionic acid is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic drugs in targeted cancer therapy, enhancing therapeutic efficacy while minimizing off-target effects. Its application in ADC development supports advancements in personalized medicine and targeted treatment strategies for malignancies.

Azido-PEG5-acid is a polyethylene glycol (PEG)-based linker designed for PROTAC (Proteolysis Targeting Chimeras) synthesis. This non-cleavable linker facilitates the development of conjugates and antibody-drug conjugates (ADCs) through its azide functionality. Azido-PEG5-acid participates in click chemistry, enabling copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing substrates, and can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN groups. Its versatility makes it valuable for various applications in chemical biology and drug discovery.

Fmoc-Lys(Pal-Glu-OtBu)-OH is a non-cleavable linker employed in the synthesis of antibody-drug conjugates (ADCs). This compound features a lysine residue with a palmitic acid-modified glutamic acid and tert-butyl ester, providing enhanced stability and solubility. Its structure also allows for use as an alkyl chain-based linker in the development of proteolysis-targeting chimeras (PROTACs), facilitating targeted protein degradation in various research applications. This versatility makes it a valuable reagent for advanced bioconjugation techniques and drug delivery systems.

Propargyl-PEG5-amine is a non-cleavable linker utilized in antibody-drug conjugates (ADCs) and PROTAC synthesis. This PEG-based compound features an alkyne functional group, enabling efficient click chemistry through copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Propargyl-PEG5-amine is valuable for researchers developing innovative therapeutic strategies involving targeted protein degradation and selective delivery of cytotoxic agents.

Maleimido-tri(ethylene glycol)-propionic acid is a cleavable linker designed for use in antibody-drug conjugates (ADCs). It facilitates the synthesis of neolymphostin-based ADC precursors, enabling site-specific conjugation to cysteine mutant trastuzumab-A114C. Additionally, this compound serves as a PEG-based linker in the development of PROTACs, contributing to research in targeted protein degradation and therapeutic applications.

DBCO-C6-acid is a non-cleavable ADC linker that facilitates the formation of antibody-drug conjugates (ADCs). Its unique DBCO moiety allows for efficient strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing compounds. This reagent is particularly useful in the synthesis of carmaphycin analogues, enabling targeted delivery of therapeutic agents for enhanced efficacy in research applications related to targeted cancer therapies.

Bis-PEG7-NHS ester is a PEG-based linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). Its NHS ester functionality facilitates conjugation, enabling the attachment of therapeutic agents to targeting antibodies or protein degradation components. This versatility supports research applications in targeted therapy and protein modulation, making it a valuable tool in drug development and protein engineering studies.

3,3'-(Propane-2,2-diylbis(sulfanediyl))dipropionic acid serves as an ROS-sensitive cleavable linker, facilitating the synthesis of antibody-drug conjugates (ADCs). Its unique mechanism allows for controlled release in response to reactive oxygen species, making it particularly valuable in the development of targeted tumor drug delivery systems. This compound is essential for researchers seeking to enhance therapeutic efficacy through precise chemical conjugation strategies.

Propargyl-PEG3-NHS ester is a PEG-based linker designed for use in the development of PROTACs and antibody-drug conjugates (ADCs). This cleavable linker features an alkyne group, allowing for efficient synthesis through click chemistry. It specifically enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules, making it a valuable tool for researchers in the fields of drug conjugation and targeted protein degradation.

Amino-PEG6-alcohol is a non-cleavable linker composed of a six-unit polyethylene glycol (PEG) chain, primarily utilized in the formulation of antibody-drug conjugates (ADCs) and PROTACs (proteolysis-targeting chimeras). This versatile PEG-based linker enhances the solubility and stability of the final conjugate, facilitating targeted therapeutic applications. It is essential for researchers working on the development of innovative therapeutic strategies in cancer and other diseases through the use of ADCs and PROTACs.

TCO-PEG12-NHS ester is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras) and antibody-drug conjugates (ADCs). This cleavable linker facilitates the conjugation of therapeutics, enabling targeted degradation of specific proteins via the ubiquitin-proteasome pathway. Its unique properties make it suitable for advancing research in targeted therapies and optimizing drug delivery systems.

Boc-NH-PEG4-CH2COOH is a cleavable linker designed for use in antibody-drug conjugates (ADCs) and PEG-based PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the construction of PROTACs by providing a flexible and stable linkage that enhances biological activity. Its applications include targeted protein degradation research and the development of innovative therapeutic strategies in oncology and other diseases.

m-PEG3-CH2CH2COOH is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs). This multifunctional PEG-based moiety also serves as a PROTAC linker, facilitating the synthesis of proteolysis-targeting chimeras. Its unique structure enhances stability and solubility, contributing to effective delivery and targeted therapy applications in chemical biology and drug development.

Propargyl-PEG3-acid is a versatile non-cleavable linker designed for antibody-drug conjugates (ADCs) and PEG-based PROTAC applications. Its structure includes a three-unit polyethylene glycol (PEG) moiety and an alkyne group, enabling efficient copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. This reagent is key in the synthesis of advanced bioconjugates, such as 6-OHDA-PEG3-yne, combining the bioactivity of 6-OHDA with the stability of the linker for targeted therapeutic applications.

Azido-PEG6-alcohol is a PEG-based linker designed for use in PROTAC synthesis, enhancing the development of targeted protein degradation strategies. This compound functions as a non-cleavable linker for antibody-drug conjugates, facilitating effective delivery of therapeutics. As a versatile click chemistry reagent, Azido-PEG6-alcohol features an azide group capable of participating in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules. Its applications extend to the fields of drug delivery and bioconjugation in chemical biology research.